Active Pharmaceutical Ingredient for vaccine manufacturing.
250 mL bottle
Vaccines
SOBERANA® 02
RBD-Tetanus Toxoid conjugate COVID-19 vaccine
https://www.finlay.edu.cu/wp-content/uploads/2023/02/Soberana-02.png 
For the prevention of symptomatic disease caused by the SARS-CoV-2 virus and severe forms and deaths from COVID-19, in people 2 years of age or older
SOBERANA® Plus
RBD dimer COVID-19 vaccine
https://www.finlay.edu.cu/wp-content/uploads/2023/02/Soberana-plus.png 
For the prevention of symptomatic disease caused by the SARS-CoV-2 virus, severe forms, and deaths from COVID-19, in persons from 2 years of age
VA-MENGOC-BC®
Meningococcal BC vaccine
https://www.finlay.edu.cu/wp-content/uploads/2019/07/Va-mengoc-BC.png 
For active immunization against meningococcal disease caused by serogroup B and C, from three months of age
vax-SPIRAL®
Trivalent leptospirosis vaccine
https://www.finlay.edu.cu/wp-content/uploads/2019/07/Vax-Spiral.png 
For active immunization against leptospirosis in persons from 15 years old with risk of acquiring the disease
vax-MEN-ACW®135
Meningococcal A, C and W135 polysaccharide vaccine
https://www.finlay.edu.cu/wp-content/uploads/2019/07/Vax-Men-ACW.png 
For active immunization against meningococcal disease caused by serogroup A, C, and W135 in persons over 2 years old
vax-TET® 5
Tetanus Vaccine
https://www.finlay.edu.cu/wp-content/uploads/2019/07/Vax-tet-5.png 
For the prevention of tetanus in all ages
vax-TyVi®
Vi polysaccharide typhoid vaccine
https://www.finlay.edu.cu/wp-content/uploads/2019/07/Vax-Tyvi.png 
For the prevention of typhoid fever in adults and children over 2 years of age
diTe-vax®
Diphtheria tetanus vaccine
https://www.finlay.edu.cu/wp-content/uploads/2019/07/Dite-Vax.png 
For the prevention of diphtheria and tetanus in adults. However, it can be used in teenagers and children from 7 years old
VA-DIFTET®
Diphtheria tetanus vaccine
https://www.finlay.edu.cu/wp-content/uploads/2019/07/VA-DIFTET.png 
For the prevention of tetanus and diphtheria in children under 7 years of age
Proyects
Clinical trials.
Attenuated vaccine against cholera (CV638)
I+D
Multivalent vaccine against meningococcal disease
Clinical trials.
Conjugated vaccine against Streptococcus pneumoniae
I+D
Conjugated vaccine against typhoid fever
IFAs
Purified polysaccharide of Neisseria meningitidis serogroup C
Purified polysaccharide of Neisseria meningitidis serogroup A
Active pharmaceutical ingredient for vaccine manufacturing
250 mL bottle
Vi Capsular Purified Polysaccharide of Salmonella Typhi
Active pharmaceutical ingredient for vaccine manufacturing
250 mL bottle
Inactivated cells of Bordetella Pertussis
Active pharmaceutical ingredient for vaccine manufacturing
20 L bottle
Sterile Purified Diphtheria Toxoid
Active pharmaceutical ingredient for vaccine manufacturing
10 L bottle
Sterile Purified Tetanus Toxoid
Active pharmaceutical ingredient for vaccine manufacturing
10 L bottle
Purified polysaccharide from Neisseria meningitidis W135
Active pharmaceutical ingredient for vaccine manufacturing
250 mL bottle
Outer membrane vesicles of Neisseria meningitidis serogroup B
Active pharmaceutical ingredient for vaccine manufacturing
500 mL bottle